论文信息 - Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease - 字舞流文

Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease

D. Hommes | G. D'Haens | G. Assche | D. S̆timac | J. Lonovics | M. Zakuciová | S. Stoinov | T. Pearce | B. Vucelić | T. Mikhajlova | S. Stoinov | D. Štimac